EMA: Regulatory procedural Advice on similar biological medicines

In April, the European Medicines Agency (EMA) published a new document on regulatory procedural advice on similar biological medicines. This paper is supposed to complement existing guidelines by a collection of questions and answers about regulatory and procedural requirements.

kapitał ludzki

fundusz społeczny

Narodowe Centrum Badań i Rozwoju

innowacyjna gospodarka

rozwój regionalny